Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Board Meeting to be held on 12-August-2026

Date: 05th August 2026 BSE Limited Phiroze Jeejeebhoy Towers 21st Floor, Dalal Street, Mumbai – 400001 BSE Scrip Code: 524322 Subject: Intimation of Board Meeting to be held on 12 th August 2026 Dear Sir/Madam, Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on 12th August 2026 at the Corporate Office of the Company situated at Chennai, inter-alia, to consider and approve the following business: 1. To consider and approve the unaudited financial results for the quarter ended on 30th June 2026 pursuant to regulation 33 of SEBI (Listed Obligations and Disclosure Requirements) Regulations, 2015. 2. Resignation of Ms. Anand Anitha (DIN: 02040505) as Director of the Company. 3. Any other agenda with permission of chair. Note: The trading window for dealing in shares in the Company for all the promoters, directors, designated employees, and the concerned connected persons has been closed till 48 hours of the announcement of the financial results. We request you to take the above information on records. Yours faithfully, For Aanjaay Industries Limited (Formerly known as Kabra Drugs Limited) Kuniamuthur Nanjappan Anand Director DIN: 03230186